GlassScriptPhysician profile
Ayesha Mannan
NPI 1497243703
$5,353.30
in general payments reported to CMS, 2019-2025
40 companies · $2,431 in 2025
The $2,431 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $353 · 2022: $270 · 2023: $577 · 2024: $1,722 · 2025: $2,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,730.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $864.15 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lundbeck LLC | $475.47 | 2023-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $407.61 | 2023-2025 | Rexulti |
| Abbvie INC. | $347.36 | 2022-2025 | |
| Novo Nordisk INC | $326.82 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $274.83 | 2021-2025 | Repatha, Otezla, Otezla |
| Viiv Healthcare Company | $245.14 | 2021 | |
| Renalytix Ai, INC. | $220.00 | 2023-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Pfizer INC. | $210.09 | 2022-2025 | |
| Astellas Pharma US INC | $167.59 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $160.96 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $144.25 | 2024-2025 | Jardiance, Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $133.17 | 2021-2024 | Verquvo, Gardasil, Capvaxive |
| Boston Scientific Corporation | $125.00 | 2023 | Watchman Access System |
| Eisai INC. | $105.45 | 2022-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $104.36 | 2023-2025 | Hillrom - Connex Spot Monitor, Hillrom - Retinavue 700 Imager |
| Medtronic, INC. | $93.30 | 2022-2023 | Venaseal |
| Genzyme Corporation | $87.98 | 2024-2025 | |
| Glaxosmithkline, LLC. | $80.23 | 2024-2025 | Trelegy Ellipta |
| Corcept Therapeutics | $65.18 | 2024 | Korlym |
| Alkermes, INC. | $64.17 | 2023-2024 | Vivitrol, Vivitrol |
| Axsome Therapeutics, INC. | $62.76 | 2025 | Auvelity |
| Paratek Pharmaceuticals, INC. | $62.54 | 2021-2024 | Nuzyra |
| Shield Therapeutics INC | $61.33 | 2023-2025 | Accrufer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.39 | 2025 | Jardiance |
| Lifenet Health | $53.68 | 2024 | Theragenesis Wound Matrix |
| Novartis Pharmaceuticals Corporation | $52.37 | 2022-2024 | |
| Esperion Therapeutics, INC. | $41.06 | 2024-2025 | Nexletol |
| Phadia US INC. | $39.69 | 2024-2025 | Immunocap |
| Bioventus LLC | $30.28 | 2023 | Theragenesis Bilayer Wound Matrix |
| Smith+Nephew, INC. | $29.92 | 2023 | Collagenase Santyl |
| E.R. Squibb & Sons, L.L.C. | $24.21 | 2023 | Eliquis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.95 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $19.79 | 2025 | |
| Mallinckrodt Hospital Products INC. | $19.08 | 2025 | Acthar |
| Ars Pharmaceuticals Operations, INC. | $17.46 | 2025 | Neffy |
| Daiichi Sankyo INC. | $17.28 | 2024 | Injectafer |
| Verona Pharma, INC. | $16.21 | 2025 | Ohtuvayre |
| Collegium Pharmaceutical, INC. | $14.84 | 2021 | |
| Advanced Oxygen Therapy INC. | $11.35 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayesha Mannan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.